The COPACC Study: Utilization, Health and Economic Evaluation of a Community-Based Primary Care Geriatric Hub at Whampoa

September 20, 2023 updated by: Geriatric Education and Research Institute

The Community for Successful Ageing (ComSA) Patient-Centered Care (COPACC) Study: Utilization, Health and Economic Evaluation of a Community-Based Primary Care Geriatric Hub at Whampoa, Singapore.

This study evaluates the Community for Successful Ageing (ComSA) Patient-Centered Medical Home (PCMH), a model of community-based primary care geriatric hub at Whampoa, Singapore.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This study evaluates the Community for Successful Ageing (ComSA) Patient-Centered Medical Home (PCMH), a model of community-based primary care geriatric hub at Whampoa, Singapore. This study aims to evaluate the impact of ComSA PCMH on health service utilisation, healthcare cost, clinical quality and effectiveness, as well as patient activation, quality of life, satisfaction and experience of care. The first component of the study is a single arm prospective pre-post cohort design, which aims to evaluate the impact on enrolled patients' self-reported health outcomes, experience of care, and cost effectiveness. The second component of the study evaluates the quality of the implementation processes via clinical quality indicators. The third component is a match-controlled retrospective pre-post study design, which aims to evaluate the impact on healthcare utilisation. Data sources include both survey data and administrative data.

Study Type

Observational

Enrollment (Actual)

184

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Singapore
      • Singapore, Singapore, 768024
        • Geriatric Education and Research Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Older adults aged 40 years and above who reside in Whampoa, Singapore, and have complex healthcare needs.

Description

Key inclusion criteria:

i. Aged 40 years and above ii. Lives in Whampoa, Singapore iii. Enrolled in PCMH after 1 September 2017

Exclusion criteria:

i. Aged less than 40 years ii. Does not live in Whampoa Singapore

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Healthcare utilisation: Primary care
Time Frame: Change from baseline to post-3 months, and to post-6 months
Primary care visits
Change from baseline to post-3 months, and to post-6 months
Healthcare utilisation: Inpatient visits
Time Frame: Change from baseline to post-3 months, and to post-6 months
Inpatient visits
Change from baseline to post-3 months, and to post-6 months
Healthcare utilisation: Specialist outpatient care
Time Frame: Change from baseline to post-3 months, and to post-6 months
Specialist outpatient clinic visits
Change from baseline to post-3 months, and to post-6 months
Healthcare utilisation: A&E
Time Frame: Change from baseline to post-3 months, and to post-6 months
A&E visits
Change from baseline to post-3 months, and to post-6 months
Patient-reported outcome measure for patient activation
Time Frame: Change from baseline to post-3 months, and to post-6 months
PAM-13
Change from baseline to post-3 months, and to post-6 months
Patient-reported outcome measure for quality of life
Time Frame: Change from baseline to post-3 months, and to post-6 months
EQ-5D-5L
Change from baseline to post-3 months, and to post-6 months
Patient-reported outcome measure for quality of life in old age
Time Frame: Change from baseline to post-3 months, and to post-6 months
CASP-19
Change from baseline to post-3 months, and to post-6 months
Patient experience of care
Time Frame: 6 months
CAHPS
6 months
Economic evaluation and cost analysis
Time Frame: Change from baseline to post-3 months, and to post-6 months
Cost comparison between intervention group and non-intervention group
Change from baseline to post-3 months, and to post-6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Geriatric Education and Research Institute

Collaborators

National Healthcare Group, Singapore
Tsao Foundation

Investigators

  • Principal Investigator: Chek Hooi Wong, Geriatric Education and Research Institute

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 4, 2017

Primary Completion (Actual)

April 30, 2020

Study Completion (Actual)

June 30, 2020

Study Registration Dates

First Submitted

October 6, 2020

First Submitted That Met QC Criteria

October 14, 2020

First Posted (Actual)

October 20, 2020

Study Record Updates

Last Update Posted (Actual)

September 21, 2023

Last Update Submitted That Met QC Criteria

September 20, 2023

Last Verified

October 1, 2020

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2017/00352

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Clinical Trials on Patient-centred care home (PCMH)

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Albania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe